- Home
- OFRM vs MGTX Comparison
OFRM vs MGTX Comparison
Compare OFRM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OFRM | MGTX |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | 153 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 684.3M | 610.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | OFRM | MGTX |
|---|---|---|
| Price | $15.85 | $9.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $27.75 | $24.57 |
| AVG Volume (30 Days) | 369.2K | ★ 918.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,391,000.00 |
| Revenue This Year | $29.42 | $141.38 |
| Revenue Next Year | $34.69 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 144.57 |
| 52 Week Low | $14.16 | $5.02 |
| 52 Week High | $27.00 | $11.85 |
Technical Indicators
Market Signals| Indicator | OFRM | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 55.98 |
| Support Level | $15.76 | $7.13 |
| Resistance Level | $17.06 | $11.85 |
| Average True Range (ATR) | 0.90 | 0.55 |
| MACD | 0.21 | -0.04 |
| Stochastic Oscillator | 66.24 | 56.08 |
Price Performance
Historical ComparisonAbout OFRM Once Upon a Farm PBC
Once Upon a Farm PBC is a provider of baby food products. The company provides childhood nutrition with real, organic, farm-fresh food-made with no added sugar, no preservatives, and nothing artificial. Its products are available at retail customers, including Target, Whole Foods, Kroger, Walmart, Publix, and Wegmans. Its key products include Smoothies, Yogurt, Milk Shakes, Oat Bars, etc.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.